Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | ACR | P10323 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22355995 | 0.88 | SLC6A3 (0.58) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL132171 | 0.85 | SLC6A3 (0.55) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL5706135 | 0.84 | SLC6A3 (0.54) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL5706263 | 0.84 | SMN1; SMN2 (0.59) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL5706062 | 0.84 | SLC6A3 (0.54) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL4391331 | 0.83 | SLC6A3 (0.59) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL4385197 | 0.83 | SLC6A3 (0.59) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL15994179 | 0.83 | SLC6A3 (0.52) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL5706195 | 0.83 | TSHR (0.59) | SLC6A3HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL29551673 | 0.82 | SLC6A3 (0.71) | SLC6A3HSD17B10KDM4EHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420850-B2 | Compounds for the synthesis of biostable polyurethane, polyurea or polyurea urethane polymers | Iberhospitex, S.A (ES) | 2013-04-16 | — | — | US | disclosed |
| US-8420850-B2 | Compounds for the synthesis of biostable polyurethane, polyurea or polyurea urethane polymers | Iberhospitex, S.A (ES) | 2013-04-16 | — | — | US | disclosed |
| US-20120059117-A1 | COMPOUNDS FOR THE SYNTHESIS OF BIOSTABLE POLYURETHANE, POLYUREA OR POLYUREA URETHANE POLYMERS | IBERHOSPITEX, S.A. | 2012-03-08 | — | — | US | disclosed |
| US-20120059117-A1 | COMPOUNDS FOR THE SYNTHESIS OF BIOSTABLE POLYURETHANE, POLYUREA OR POLYUREA URETHANE POLYMERS | IBERHOSPITEX, S.A. | 2012-03-08 | — | — | US | disclosed |
| WO-2011141341-A1 | COMPOUNDS FOR THE SYNTHESIS OF BIOSTABLE POLYURETHANE, POLYUREA OR POLYUREA URETHANE POLYMERS | IBERHOSPITEX, S.A. (ES) | 2011-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059117-A1 | COMPOUNDS FOR THE SYNTHESIS OF BIOSTABLE POLYURETHANE, POLYUREA OR POLYUREA URETHANE POLYMERS | PUF60, UMPS, UGP2 | SLC6A3 2451/4885HSD17B10 4332/4885KDM4E 1632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.